COVID-19 vaccine hesitancy in people with migratory backgrounds: a cross-sectional study among Turkish- and German-speaking citizens in Munich.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
06 Dec 2021
Historique:
received: 11 05 2021
accepted: 03 12 2021
entrez: 7 12 2021
pubmed: 8 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

This study aimed to investigate the knowledge, attitudes, behaviors, and COVID-19 vaccine hesitancy of people with migratory backgrounds among Turkish- and German-speaking patients in Munich. Primary outcomes were the intention to get vaccinated for COVID-19 and COVID-19 knowledge levels (25 true/false items). Other variables included demographics, attitudes to COVID-19 and vaccination (7 items), and behaviors regarding COVID-19 (7 items). The attitude and behavior questions had 5-point Likert scales. Of the 10 Turkish-speaking family physicians in Munich, six agreed to administer Turkish or German questionnaires to consecutive patients in February 2021. Furthermore, participants with either citizenship, country of origin, native language, or place of birth being non-German were categorized as "Having a migratory background." Data from 420 respondents were analyzed. Women constituted 41.4% (n = 174), the mean age was 42.2 ± 15.5 years, 245 (58.3%) preferred the Turkish questionnaire, 348 (82.9%) had a migratory background, and 197 (47.9%) intended to be vaccinated. The mean knowledge, attitude, and behavioral scores were 21.5 ± 3.2 (max = 25), 3.7 ± 0.8 (max = 5), and 4.0 ± 0.5 (max = 5). While 42.3% (n = 145) of the participants with a migratory background considered getting vaccinated, this proportion was 76.5% (n = 52) for non-immigrant Germans (Chi-square = 26.818, p < 0.001). Non-migratory background (odds ratio (OR): 3.082), high attitude scores (OR: 2.877), male sex (OR: 2.185), years of schooling (OR: 1.064), and age (OR: 1.022) were positively associated with vaccination intention. We suggest initiating or supporting projects run by persons or groups with immigrant backgrounds to attempt to elaborate and change their vaccination attitudes.

Sections du résumé

BACKGROUND BACKGROUND
This study aimed to investigate the knowledge, attitudes, behaviors, and COVID-19 vaccine hesitancy of people with migratory backgrounds among Turkish- and German-speaking patients in Munich.
METHODS METHODS
Primary outcomes were the intention to get vaccinated for COVID-19 and COVID-19 knowledge levels (25 true/false items). Other variables included demographics, attitudes to COVID-19 and vaccination (7 items), and behaviors regarding COVID-19 (7 items). The attitude and behavior questions had 5-point Likert scales. Of the 10 Turkish-speaking family physicians in Munich, six agreed to administer Turkish or German questionnaires to consecutive patients in February 2021. Furthermore, participants with either citizenship, country of origin, native language, or place of birth being non-German were categorized as "Having a migratory background." Data from 420 respondents were analyzed.
RESULTS RESULTS
Women constituted 41.4% (n = 174), the mean age was 42.2 ± 15.5 years, 245 (58.3%) preferred the Turkish questionnaire, 348 (82.9%) had a migratory background, and 197 (47.9%) intended to be vaccinated. The mean knowledge, attitude, and behavioral scores were 21.5 ± 3.2 (max = 25), 3.7 ± 0.8 (max = 5), and 4.0 ± 0.5 (max = 5). While 42.3% (n = 145) of the participants with a migratory background considered getting vaccinated, this proportion was 76.5% (n = 52) for non-immigrant Germans (Chi-square = 26.818, p < 0.001). Non-migratory background (odds ratio (OR): 3.082), high attitude scores (OR: 2.877), male sex (OR: 2.185), years of schooling (OR: 1.064), and age (OR: 1.022) were positively associated with vaccination intention.
CONCLUSIONS CONCLUSIONS
We suggest initiating or supporting projects run by persons or groups with immigrant backgrounds to attempt to elaborate and change their vaccination attitudes.

Identifiants

pubmed: 34872525
doi: 10.1186/s12879-021-06940-9
pii: 10.1186/s12879-021-06940-9
pmc: PMC8647512
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1214

Informations de copyright

© 2021. The Author(s).

Références

Soc Sci Med. 1995 Sep;41(6):819-28
pubmed: 8571153
Int J Environ Res Public Health. 2021 Jan 16;18(2):
pubmed: 33467179
Int J Public Health. 2010 Oct;55(5):357-71
pubmed: 20437193
J Migr Health. 2021;4:100050
pubmed: 34075367
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Hum Vaccin Immunother. 2020 May 3;16(5):1034-1039
pubmed: 32027218
Eur J Public Health. 2014 Aug;24 Suppl 1:80-6
pubmed: 25108002
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713
Health Rep. 2019 Apr 17;30(4):3-11
pubmed: 30994921
Gerontologist. 2019 Mar 14;59(2):205-214
pubmed: 30383212
Dtsch Med Wochenschr. 2015 Jan;140(2):e14-20
pubmed: 25612288
Pediatr Infect Dis J. 2021 Apr 1;40(4):e134-e136
pubmed: 33410650
BMC Public Health. 2006 Oct 11;6:249
pubmed: 17034625
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
BMJ Open. 2017 Aug 11;7(8):e015520
pubmed: 28801401
Int Migr Rev. 2008;42(4):861-876
pubmed: 21048888
BMJ. 2021 Jan 14;372:m4921
pubmed: 33446485
BMC Pregnancy Childbirth. 2020 Mar 12;20(1):158
pubmed: 32164606

Auteurs

Zekeriya Aktürk (Z)

Institute of General Practice and Health Services Research, School of Medicine, Technical University of Munich, Orleansstr. 47, 81667, Munich, Germany. zekeriya.aktuerk@tum.de.

Klaus Linde (K)

Institute of General Practice and Health Services Research, School of Medicine, Technical University of Munich, Orleansstr. 47, 81667, Munich, Germany.

Alexander Hapfelmeier (A)

Institute of General Practice and Health Services Research, School of Medicine, Technical University of Munich, Orleansstr. 47, 81667, Munich, Germany.
Institute for AI and Medical Informatics in Medicine, School of Medicine, Technical University of Munich, Munich, Germany.

Raphael Kunisch (R)

Institute of General Practice, School of Medicine, Universitätsklinikum Erlangen, Erlangen, Germany.

Antonius Schneider (A)

Institute of General Practice and Health Services Research, School of Medicine, Technical University of Munich, Orleansstr. 47, 81667, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH